Cian Healthcare Share Price Today | Stock Price & Cian Healthcare Share Screener
Track the current Cian Healthcare share price and stock price live with TickJournal's free stock screener. Check CHCL 52-week chart for the annual price range and momentum. Use the Cian Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Cian Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Cian Healthcare Share Price Chart
Track the current stock price of Cian Healthcare with an interactive chart. Analyse CHCL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Cian Healthcare stock quote in one place.
Cian Healthcare Company Profile - Fundamental Screener
Screen Cian Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CHCL shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE05BN01019.
Company Details
Classification
Identifiers and Leadership
Cian Healthcare Balance Sheet Screener
Screen CHCL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹156 against total liabilities of ₹156, down from ₹161 in 2024.
Latest statistics put total assets at ₹156 and shareholder funds at ₹32, with a leverage ratio of 1.22.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
Assets |
||||||
| Total Assets | 156 | 161 | 161 | 166 | 157 | 157 |
| Current Assets | 71 | 72 | 74 | 79 | 63 | 54 |
| Fixed Assets | 35 | 39 | 45 | 50 | 37 | 39 |
Liabilities |
||||||
| Total Liabilities | 156 | 161 | 161 | 166 | 157 | 157 |
| Current Liabilities | 9 | 37 | 38 | 41 | 41 | 50 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||
| Total Equity | 32 | 58 | 58 | 56 | 58 | 58 |
| Share Capital | 25 | 25 | 25 | 25 | 23 | 23 |
| Reserves & Surplus | 7 | 33 | 33 | 31 | 35 | 35 |
Cian Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Cian Healthcare income statement and profit fundamentals. Analyze CHCL quarterly results. Cian Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹31 and net profit of ₹-26.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||
| Revenue | 0 | 31 | 62 | 69 | 78 | 74 | 58 |
| Expenses | 0 | 38 | 51 | 56 | 74 | 62 | 50 |
Operating Costs and Margins | |||||||
| EBITDA | 0 | -6 | 11 | 13 | 5 | 12 | 8 |
| Operating Profit % | 0.00% | -22.00% | 18.00% | 18.00% | 5.00% | 16.00% | 13.00% |
| Depreciation | 0 | 4 | 6 | 5 | 4 | 4 | 4 |
| Interest | 0 | 3 | 6 | 6 | 6 | 8 | 7 |
Profit and Earnings | |||||||
| Profit Before Tax | 0 | -26 | 0 | 2 | -6 | 1 | -4 |
| Tax | 0 | 0 | -1 | 0 | -1 | 1 | 0 |
| Net Profit | 0 | -26 | 1 | 2 | -6 | 0 | -4 |
| EPS | 0.00 | -10.39 | 0.34 | 0.81 | -2.21 | 0.02 | -1.62 |
Cian Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen CHCL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹21, and net cash flow was an inflow of ₹17.
Over the same period, investing activities provided ₹0 and financing activities used ₹4.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||
| Operating Activities | 21 | 12 | 5 | 9 | 6 | -7 |
| Investing Activities | 0 | -2 | 3 | 1 | 3 | -27 |
Financing and Net Cash | ||||||
| Financing Activities | -4 | -10 | -7 | -11 | -10 | 36 |
| Net Cash Flow | 17 | 0 | 0 | -1 | -1 | 1 |
Cian Healthcare Shareholding Pattern Screener
See Cian Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Cian Healthcare promoter holding and ownership changes for CHCL on TickJournal, and see how institutional stock price moves affect the market.
In 2025-Sept, promoters held 27.10%, foreign institutions 0.00%, domestic institutions 0.00% and the public 63.77%, spread across 1,662 shareholders.
The shareholder count was 1,662 in 2025-Sept, compared with 1,501 in 2025-Mar.
| Item | 2025-Sept | 2025-Mar | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Sept | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 27.10% | 27.10% | 27.10% | 27.10% | 27.10% | 49.62% | 51.85% | 66.26% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.79% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 63.77% | 63.56% | 59.23% | 56.59% | 55.78% | 41.08% | 41.88% | 24.00% |
| Other Holding | 9.12% | 9.34% | 13.67% | 16.31% | 17.12% | 9.30% | 6.27% | 8.95% |
| Shareholder Count | 1,662 | 1,501 | 1,088 | 831 | 880 | 672 | 454 | 418 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Cian Healthcare. Cian Healthcare dividend yield can be compared with peers and other stocks in the market.
Cian Healthcare Stock Index Membership - Nifty & Sensex
See which indices include Cian Healthcare stock. Check CHCL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Cian Healthcare Market Events Screener - Corporate Actions
Get Cian Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Cian Healthcare stock events that may affect CHCL share price, along with derivatives, futures and options activity and sector gainers.
2 corporate actions are listed, the most recent entry being Annual General Meeting dated December 17, 2025, with a record date of December 17, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-12-17 | 2025-12-17 | Annual General Meeting | NA | -17.61% |
| 2024-10-08 | 2024-10-08 | Annual General Meeting | NA | -9.16% |
Cian Healthcare Competitors Screener - Peer Stocks Comparison
Screen CHCL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Cian Healthcare Company Announcements - News & Reports Screener
Screen CHCL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated and .
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | - | |
| Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - | |
| Announcement under Regulation 30 (LODR)-Resignation of Director | - | |
| Announcement under Regulation 30 (LODR)-Resignation of Managing Director | - | |
| Announcement under Regulation 30 (LODR)-Change in Management | - | |
| Board Meeting Outcome for Outcome Of The First Meeting (CIAN/RPIC/2025-26/01) Of The Resolution Plan Implementation Committee (Implementation Committee) Held On December 24 2025. | - | |
| 2026-10-03 | Constitution Of The Resolution Plan Implementation Committee Of Cian Healthcare Limited Pursuant To The Approval Of The Resolution Plan By The Honble NCLT. | - |
| 2026-10-01 | Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal | - |
| 2026-09-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-30 | Summary Of Proceedings Of The 22Nd Annual General Meeting Of The Company Held On December 17 2025. | - |
| 2026-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-11-29 | Clarification Regarding Extension Of Annual General Meeting (AGM) Of Cian Healthcare Limited (Company). | - |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-25 | Corrigendum To The Notice Of 22Nd Annual General Meeting ("AGM") Of The Company Scheduled To Be Held On Wednesday December 17 2025 At 10:00 A.M. Through Video Conferencing/Other Audio-Visual Means. | - |
| 2025-11-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-24 | Reg. 34 (1) Annual Report. | - |
| 2025-11-24 | Notice Of The 22Nd (Twenty-Second) Annual General Meeting Of The Members Of Cian Healthcare Limited Scheduled To Be Held On Wednesday December 17 2025 At 10:00 A.M. Through Video Conference /Other Audio-Visual Means ("VC / OAVM"). | - |
| 2025-11-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-21 | Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 By Cian Healthcare Limited (Company) | - |
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 0.39. Market capitalisation stands at ₹12.73 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 6 balance sheet periods, 7 income statement periods, 6 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.